User menu

Rituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II lymphoma study Association trial

Bibliographic reference Mounier, N. ; El Gnaoui, T. ; Tilly, H. ; Canioni, D. ; Sebban, C. ; et. al. Rituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II lymphoma study Association trial. In: Haematologica : journal of hematology, Vol. 98, no.11, p. 1726-1731 (2013)
Permanent URL http://hdl.handle.net/2078.1/135688